2388 GENES FOUNDi
Show / hide columns XML | RDF | TSV | Page of 48 | next »
Genei
Gene descriptioni x
Protein classi x
Tissue
Cell
Pathology
Subcellular locationi x
Prognostic p-valuei x
RNA cancer categoryi x
RNA tissue categoryi x
AATKApoptosis associated tyrosine kinaseEnzymes
Predicted intracellular proteins
Predicted membrane proteins
MitochondriaMixedTissue enhanced
ABCA8ATP binding cassette subfamily A member 8Predicted membrane proteins
Transporters
Nucleoplasm
Cytosol
MixedMixed
ABCB1ATP binding cassette subfamily B member 1Cancer-related genes
CD markers
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Nucleoplasm
Focal adhesion sites
Cytosol
Renal cancer: 2.95e-4
Pancreatic cancer: 3.33e-4
Tissue enhancedTissue enhanced
ABCB9ATP binding cassette subfamily B member 9Predicted intracellular proteins
Predicted membrane proteins
Transporters
VesiclesGlioma: 4.62e-4
MixedTissue enhanced
ABCC11ATP binding cassette subfamily C member 11Predicted intracellular proteins
Predicted membrane proteins
Group enrichedTissue enriched
ABCC3ATP binding cassette subfamily C member 3Cancer-related genes
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Plasma membraneRenal cancer: 4.68e-6
Pancreatic cancer: 9.57e-4
MixedMixed
ABCC4ATP binding cassette subfamily C member 4Plasma proteins
Predicted membrane proteins
Transporters
Renal cancer: 2.25e-10
Endometrial cancer: 9.89e-4
Tissue enrichedTissue enhanced
ABCC6ATP binding cassette subfamily C member 6Cancer-related genes
Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
Plasma membraneLiver cancer: 3.82e-4
Tissue enhancedTissue enhanced
ABCC8ATP binding cassette subfamily C member 8Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Nucleoli
Golgi apparatus
Cytosol
Tissue enrichedTissue enhanced
ABCC9ATP binding cassette subfamily C member 9Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Nucleoplasm
Cytosol
Renal cancer: 1.85e-5
MixedMixed
ABCG2ATP binding cassette subfamily G member 2 (Junior blood group)Cancer-related genes
CD markers
Predicted intracellular proteins
Predicted membrane proteins
Nucleus
Plasma membrane
MixedTissue enhanced
ABI3BPABI family member 3 binding proteinPlasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Renal cancer: 6.14e-4
MixedMixed
ABLIM2Actin binding LIM protein family member 2Predicted intracellular proteins
Nucleoplasm
Mitochondria
MixedTissue enhanced
ABLIM3Actin binding LIM protein family member 3Plasma proteins
Predicted intracellular proteins
Nucleoplasm
Plasma membrane
Cell Junctions
Renal cancer: 1.28e-4
MixedTissue enhanced
ABOABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferasePredicted membrane proteins
MixedTissue enhanced
ACBD7Acyl-CoA binding domain containing 7Predicted intracellular proteins
Vesicles
Cytosol
MixedTissue enriched
ACE2Angiotensin I converting enzyme 2Enzymes
FDA approved drug targets
Predicted membrane proteins
Renal cancer: 2.12e-5
Liver cancer: 4.21e-4
Tissue enhancedGroup enriched
ACER2Alkaline ceramidase 2Enzymes
Predicted membrane proteins
Tissue enhancedGroup enriched
ACOT11Acyl-CoA thioesterase 11Predicted intracellular proteins
CytosolRenal cancer: 3.07e-8
Colorectal cancer: 9.37e-4
MixedMixed
ACOX2Acyl-CoA oxidase 2Enzymes
Predicted intracellular proteins
Vesicles
Cytosol
Tissue enhancedTissue enhanced
ACPPAcid phosphatase, prostateCancer-related genes
Enzymes
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enrichedTissue enriched
ACRBPAcrosin binding proteinPredicted secreted proteins
Nucleoplasm
Vesicles
MixedTissue enriched
ACSM1Acyl-CoA synthetase medium-chain family member 1Enzymes
Predicted intracellular proteins
Predicted membrane proteins
Group enrichedTissue enriched
ACSM3Acyl-CoA synthetase medium-chain family member 3Enzymes
Predicted intracellular proteins
Renal cancer: 9.88e-6
Ovarian cancer: 1.97e-4
MixedTissue enhanced
ACSM5Acyl-CoA synthetase medium-chain family member 5Enzymes
Predicted intracellular proteins
Group enrichedTissue enriched
ACSS3Acyl-CoA synthetase short-chain family member 3Enzymes
Predicted membrane proteins
MitochondriaRenal cancer: 0.00e+0
MixedMixed
ACTA1Actin, alpha 1, skeletal muscleDisease related genes
Plasma proteins
Predicted intracellular proteins
Group enrichedTissue enriched
ACTL10Actin like 10Predicted secreted proteins
MixedTissue enriched
ACTRT3Actin related protein T3Predicted intracellular proteins
NucleoplasmEndometrial cancer: 4.11e-4
MixedTissue enriched
ADAM12ADAM metallopeptidase domain 12Predicted membrane proteins
Predicted secreted proteins
Transporters
Plasma membraneRenal cancer: 2.39e-14
MixedTissue enriched
ADAM22ADAM metallopeptidase domain 22Predicted membrane proteins
Predicted secreted proteins
Cell JunctionsMixedTissue enhanced
ADAM28ADAM metallopeptidase domain 28Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Plasma membrane
Mitochondria
Endometrial cancer: 3.17e-4
MixedTissue enhanced
ADAMTS13ADAM metallopeptidase with thrombospondin type 1 motif 13Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted secreted proteins
MixedMixed
ADAMTS14ADAM metallopeptidase with thrombospondin type 1 motif 14Cancer-related genes
Plasma proteins
Predicted secreted proteins
CytosolMixedTissue enhanced
ADAMTS15ADAM metallopeptidase with thrombospondin type 1 motif 15Predicted secreted proteins
CytosolUrothelial cancer: 5.63e-5
Glioma: 9.00e-4
Lung cancer: 9.72e-4
MixedTissue enhanced
ADAMTS3ADAM metallopeptidase with thrombospondin type 1 motif 3Cancer-related genes
Predicted secreted proteins
Intermediate filamentsMixedTissue enhanced
ADAMTS5ADAM metallopeptidase with thrombospondin type 1 motif 5Cancer-related genes
Predicted secreted proteins
NucleoplasmRenal cancer: 2.46e-4
Thyroid cancer: 8.54e-4
MixedTissue enhanced
ADAMTS7ADAM metallopeptidase with thrombospondin type 1 motif 7Plasma proteins
Predicted secreted proteins
VesiclesStomach cancer: 9.53e-4
MixedTissue enhanced
ADAMTSL3ADAMTS like 3Predicted secreted proteins
VesiclesMixedMixed
ADAMTSL5ADAMTS like 5Predicted intracellular proteins
Predicted secreted proteins
Golgi apparatusMixedTissue enhanced
ADCY1Adenylate cyclase 1Cancer-related genes
Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
MitochondriaMixedTissue enhanced
ADCY7Adenylate cyclase 7Enzymes
Predicted intracellular proteins
Predicted membrane proteins
CytosolCervical cancer: 5.31e-4
MixedMixed
ADCYAP1R1ADCYAP receptor type IG-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Transporters
VesiclesEndometrial cancer: 5.78e-4
Tissue enrichedTissue enhanced
ADGRB2Adhesion G protein-coupled receptor B2G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
CentrosomeLung cancer: 4.02e-5
Breast cancer: 6.46e-4
Tissue enhancedTissue enriched
ADGRD1Adhesion G protein-coupled receptor D1G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Nucleus
Cytosol
Liver cancer: 9.27e-4
MixedTissue enhanced
ADGRF1Adhesion G protein-coupled receptor F1G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Renal cancer: 1.35e-5
MixedTissue enhanced
ADGRG2Adhesion G protein-coupled receptor G2Disease related genes
G-protein coupled receptors
Plasma proteins
Potential drug targets
Predicted membrane proteins
Plasma membrane
Cytosol
Tissue enhancedTissue enriched
ADGRG5Adhesion G protein-coupled receptor G5G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Nucleoplasm
Nuclear membrane
Vesicles
Cervical cancer: 4.25e-4
MixedTissue enhanced
ADHFE1Alcohol dehydrogenase, iron containing 1Enzymes
Predicted intracellular proteins
VesiclesRenal cancer: 4.55e-5
Breast cancer: 5.76e-5
Liver cancer: 9.90e-5
MixedMixed
ADM2Adrenomedullin 2Predicted secreted proteins
Thyroid cancer: 2.72e-4
MixedTissue enhanced
Page of 48 | next »